Additionally, HBV-specific T-cell responses exhibited an increasing trend one year after cART initiation compared to baseline.
← all excerpts
Baseline HBsAg quantitative and CD4 T cell counts are associated with HBsAg loss in people living with HIV/HBV coinfection after combined antiretroviral therapy.
1
—
—